Friday's 5 Quotes for Primary Care 5-12-2023

Each of the quotes that follow is taken from a study reviewed on Patient Care® during the past week and was chosen for the research team’s passion about the clinical implications of their findings and for their potential impact on primary care practice.

©Gorodenkoff/Adobe Stock

Black women are more likely to be diagnosed with later stage breast cancer and at younger ages and are more likely than White women to have aggressive disease. Moreover, Black women are ~40% more likely to die from breast cancer than White women. The higher mortality rate persists after accounting for age differences and stage at diagnosis and despite the similar or higher rate of self-reported mammography screening among Black women vs all women (84.5% vs 78%, respectively).

©mraoraor/Adobe stock

Nearly one-third of adult US women who have ever tried to obtain a prescription or refill for a contraceptive pill, patch, or ring reported difficulties doing so. The FDA's approval for OTC use "would address a key unmet need for contraceptive access, be a groundbreaking expansion for women's health nationwide, and a step forward toward ensuring people can have improved access to contraception without unnecessary barriers."

©Steve Heap/Adobe Stock

Access to medications for OUD specifically "is a pillar of the HHS Overdose Prevention Strategy,” said Miriam E. Delphin-Rittmon, HHS assitant secretary for mental health and substance use and leader of SAMHSA. “We strongly support policies that promote access to effective and safe treatment for opioid use disorder, including through telemedicine platforms, and ensuring continued access to necessary controlled medications past the COVID-PHE.”

©Dave/Adobe Stock

Individuals with overweight or obesity treated with a novel dual glucagon/glucagon-like peptide-1 receptor agonist reached up to a 14.9% weight loss at 46 weeks. None of the study participants had type 2 diabetes. The complete data set will be presented at the 2023 American Diabetes Association’s annual meeting in June, and will include analysis of all participants receiving the maintenance dose which may demonstrate even greater weight loss than observed in these midstage findings.

©yepifanovahelen/Adobe Stock

Infants born with neonatal opioid withdrawal syndrome cared for with the “Eat, Sleep, Console” (ESC) approach were 63% less likely to receive medication as part of treatment and were discharged home approximately 6.7 days earlier compared to neonates who received standard of care. ESC relies on a function-based vs extensive scoring-based approach to assessment and management of neonatal abstinence syndrome.